Top View
- Comparison Between a New Once-Daily, Bronchodilating Drug, Bambuterol, and Terbutaline Sustained-Release, Twice Daily
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Study Protocol
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Amended Clinical Trial Protocol 02
- Justification
- 2019 Equine Prohibited Substances List
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Literature Search Strategy for Treatment of Stable
- WO 2014/113638 Al 24 July 2014 (24.07.2014) P O P C T
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- List of Contraindications to Propranolol And/Or Etodolac
- Crystalline Levosalbutamol Sulphate (Form II)
- Sample Pages from BNF 71, Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2016 BNF 71 Airways Disease, Obstructive 217
- ONLINE SUPPLEMENTARY TABLES Supplementary Table 1. Inclusion
- Real-Life Effectiveness Evaluation of Asthma Treatment in Korea
- Lydia Normal.Dot
- Non-Interventional Study Protocol
- Wo 2009/151569 A2
- A Comparison of Two Long-Acting P-Agonists, Oral Bambuterol and Inhaled Salmeterol, in the Treatment of Moderate to Severe Asthmatic Patients with Nocturnal Symptoms
- Risk of Non-Fatal Cardiac Failure and Ischaemic Heart Disease with Long
- Therapeutic Equivalence Between Bambuterol, 1 0 Mg Once Daily, And
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Novel Combination of Theophylline and Bambuterol As a Potential Treatment of Hypoxemia in Humans
- Scheduling of Medicines and Poisons
- Pharmaceutical Appendix to the Tariff Schedule 2
- Comparative Study of Racemic Salbutamol and Levosalbutamol in Patients with Bronchial Asthma
- Chirality of Β2-Agonists. an Overview of Pharmacological Activity, Stereoselective Analysis, and Synthesis
- Evidence Table 4.11B: Add-On Drugs for Inhaled Steroids: Long Acting Or Oral B2 Agonists
- Pharmaceutical Compositions Containing Formoterol Pharmazeutische Zusammensetzung Enthaltend Formoterol Compositions Pharmaceuticales Comprenant Formoterol
- QVA149 / Indacaterol / Glycopyrronium Bromide
- Enantiomeric Separation of Β2-Agonists on Macrocyclic
- ICD-10-CM Table of Drugs 2019
- NAIA Banned Drugs It Is Your Responsibility to Check with the Appropriate Or Designated Athletics Staff Before Using Any Substance
- Novartis Basic Registration Template
- FIXED DOSE COMBINATIONS APPROVED by DCG (I) SINCE 1961 to 28Th JUNE 2019
- Short-Acting Beta Agonists and Risk of Myocardial Ischaemia Final SPC
- Adrenoceptor Agonists in Asthma Management